EUVIMEDEUVIMED entdecken
Crossref

Methylglyoxal Reshapes Hepatic and Adipose Tissue Metabolism and Increases Viability of Lymphocytes

Naiara Cristina Lucredi, Lucas Paulo J Saavedra, Silvano Piovan, Emanuele P Lima, Mariane Aparecida F Godoy, Rogério Marchiosi, Verônica Elisa P Vicentini, Paulo Cezar F Mathias, Anacharis B Sá-Nakanishi, Lívia Bracht, Claudia C S Chini, Eduardo N Chini und 2 weitere

Cellular Physiology and Biochemistry · 2025

DOI: 10.33594/000000770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, 2025. Verfasst von Naiara Cristina Lucredi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, State University of Maringá, 87020900, PR, Brazil. Hauptthemen laut MEDLINE: Pyruvaldehyde, Liver, Adipose Tissue, Lymphocytes. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Paul F. Glenn Laboratories For Aging Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Methylglyoxal (MG) is associated with the development of metabolic disorders that modify the hepatic energetic metabolism in different ways. However, not much is known about the effects of MG on energy metabolism in healthy liver cells. Therefore, this study investigated the effects of daily MG administration to Wistar rats on hepatic and fat tissue energetic metabolism.

Methods

Rats received MG intraperitoneally at doses of 100 or 200 mg/kg for seven consecutive days in acute approach or at a dose of 25 mg/kg for one month in the chronic approach. Metabolic pathways were measured in isolated perfused livers (glycogen catabolism, gluconeogenesis and ketogenesis) as well in adipose tissue. Activities and mRNA expressions of gluconeogenic enzymes were assessed in the liver and the viability of human lymphocytes were evaluated in vitro.

Results

MG displayed systemic inflammation and the metabolic changes were similar to those of widespread catabolic diseases. MG and advanced glycation end-products stimulated lymphocyte proliferation, and MG increased the hepatic interleukin-6 expression. Rats that received MG developed insulin resistance. Gluconeogenesis was diminished and glycolysis was stimulated in livers of rats that received MG. Two factors contribute to this outcome: a deficiency in mitochondrial energy supply and a much more significant downregulation of gluconeogenic enzymes. The adipose tissue metabolism was modified in a way that the AMPK-induced lipolysis was increased in the retroperitoneal fat, but not in the mesenteric fat. Ketogenesis was increased and triglycerides content was decreased in the liver.

Conclusion

To what degree the modifications in hepatic metabolism found in MG-exposed rats can be translated to patients with a high-grade inflammation and cirrhosis is uncertain. However, it is unlikely that the strong catabolic state induced by MG would not contribute in some way to the hepatic dysfunction in advanced liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyruvaldehydeLiverAdipose TissueLymphocytesAnimalsRats, WistarRatsMaleGluconeogenesisHumansCell SurvivalEnergy MetabolismInterleukin-6Glycation End Products, Advanced

Stichwörter der Autor:innen

Methylglyoxal; Liver diseases; Advanced glycation end products; Gluconeogenesis…

Substanzen

PyruvaldehydeInterleukin-6Glycation End Products, Advanced

Autor:innen und Institutionen

  • Department of Biochemistry, State University of Maringá, 87020900, PR, Brazil.
  • Department of Biotechnology, Genetics, and Cellular Biology, State University of Maringá, PR, Brazil.
  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Department of Biochemistry, State University of Maringá, 87020900, PR, Brazil, jfcomar@uem.br.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Paul F. Glenn Laboratories For Aging Research
  • National Cancer Institute - NIH
  • Mayo Clinics and Foundation

Zitieren

APA

Lucredi, N. C., Saavedra, L. P. J., Piovan, S., Lima, E. P., Godoy, M. A. F., Marchiosi, R., Vicentini, V. E. P., Mathias, P. C. F., Sá-Nakanishi, A. B., Bracht, L., Chini, C. C. S., Chini, E. N., Bracht, A., & Comar, J. F. (2025). Methylglyoxal Reshapes Hepatic and Adipose Tissue Metabolism and Increases Viability of Lymphocytes. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000770

Vancouver

Lucredi NC, Saavedra LPJ, Piovan S, Lima EP, Godoy MAF, Marchiosi R, et al. Methylglyoxal Reshapes Hepatic and Adipose Tissue Metabolism and Increases Viability of Lymphocytes. Cellular Physiology and Biochemistry. 2025. doi:10.33594/000000770

BibTeX
@article{Lucredi2025,
  author = {Lucredi, Naiara Cristina and Saavedra, Lucas Paulo J and Piovan, Silvano and Lima, Emanuele P and Godoy, Mariane Aparecida F and Marchiosi, Rogério and Vicentini, Verônica Elisa P and Mathias, Paulo Cezar F and Sá-Nakanishi, Anacharis B and Bracht, Lívia and Chini, Claudia C S and Chini, Eduardo N and Bracht, Adelar and Comar, Jurandir F},
  title = {Methylglyoxal Reshapes Hepatic and Adipose Tissue Metabolism and Increases Viability of Lymphocytes},
  journal = {Cellular Physiology and Biochemistry},
  year = {2025},
  doi = {10.33594/000000770}
}
Kostenlos starten →